Glysat PM 1mg/500mg/15mg Tablet SR
Marketer
Events Pharma
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Glysat PM 1mg/500mg/15mg Tablet SR
Glysure Extended-Release Tablets (1mg/500mg/15mg) combine medications to manage blood glucose. This formulation, used alongside diet and exercise, enhances glycemic control in adults with type 2 diabetes. It facilitates efficient insulin use, thus reducing blood sugar. Adhere strictly to your physician's prescribed dosage and frequency; take with food to prevent gastric distress. Missed doses should be taken promptly unless nearing the next scheduled dose; then, omit the missed one and resume your regular regimen. Never double the dose; overdose risks dangerously low blood sugar (hypoglycemia). Concomitant use with other diabetes medications, alcohol, or skipped meals increases hypoglycemia risk; regular blood sugar monitoring is crucial. Common side effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Disclose any kidney, liver, or heart conditions to your doctor before starting treatment, as should pregnant or nursing individuals. Kidney function tests will be assessed prior to treatment commencement. Limit alcohol consumption, as it may heighten side effect probability.
Primary Ingredients of Glysat PM 1mg/500mg/15mg Tablet SR
No text provided to rephrase.
Uses of Glysat PM 1mg/500mg/15mg Tablet SR
Managing type 2 diabetes
Major Benefits of Glysat PM 1mg/500mg/15mg Tablet SR:
Follow your physician's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glysat PM 1mg/500mg/15mg Tablet SR whole; avoid chewing, crushing, or breaking it. Administer this medication with food.
Common Side effects of Glysat PM 1mg/500mg/15mg Tablet SR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Glysat PM 1mg/500mg/15mg Tablet SR:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Glysat PM 1mg/500mg/15mg Tablet SR whole; do not break, crush, or chew it. Administer this medication with food.
How Glysat PM 1mg/500mg/15mg Tablet SR works:
Glysat PM 1mg/500mg/15mg Extended-Release Tablets combine glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents. This triple-drug approach enhances blood glucose management when monotherapy or dual therapy proves insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, reducing blood sugar. Metformin, a biguanide, acts through multiple pathways: decreasing hepatic glucose production, slowing intestinal glucose absorption, and improving insulin responsiveness. Pioglitazone, a thiazolidinedione, further augments insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Glysat PM 1mg/500mg/15mg SR tablets with alcohol is inadvisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
The use of Glysat PM 1mg/500mg/15mg sustained-release tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against any risks prior to prescribing this medication. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Glysat PM 1mg/500mg/15mg tablet's use while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving may be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with kidney impairment should use Glysat PM 1mg/500mg/15mg SR tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates Glysat PM 1mg/500mg/15mg SR tablet use. Physician consultation is essential. Regular kidney function monitoring is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Glysat PM 1mg/500mg/15mg SR tablets cautiously, potentially requiring dose modification. Medical advice is necessary. Glysat PM 1mg/500mg/15mg SR tablets are contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Glysat PM 1mg/500mg/15mg Tablet SR :
Should you forget to take a Glysat PM 1mg/500mg/15mg Tablet SR, administer it immediately upon remembering. However, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take more than the prescribed dose.
Facts to Know About Glysat PM 1mg/500mg/15mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently